arcoris bio raises CHF 6.3 M

arcoris bio is developing MUSE, a nanotechnology platform for multiplexed biomarker detection in research and diagnostics. The CHF 6.3 million seed round, in which private investors also took part, will fund industrialisation and new products.

Announced on
Round
Seed
Amount
CHF 6.3 M
Location
Schlieren, canton of Zurich
Sector
Health & medtech, Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic